Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PAY ATTENTION. PLEASE. EVEN IF THERE IS A DELAY, IT WILL BE BECAUSE OF LABELLING, NOT A CRL.
AS SUCH, A DELAY AS A RESULT OF LABELLING IS DEFACTO APPROVAL.
LET ME KNOW IF I NEED TO REPEAT THE ABOVE.
I HOPE ANYONE HERE ISN’T TOO DEEP INTO A SHORT POSITION. ACTUALLY, I DO. I DO HOPE ALL SHORTS BURN.
BLAH
LOL. NO.
LOL. NO.
LOL YOU WERE THE ONLY ONE, EH?
Hedging loss based on FDA docs and total # shares owned. Those jackals helped start the initial crater last Monday with the large dump.
Glad they lost money, honestly. Lord knows retail always gets screwed
Good luck out there!
That’s a bit of a stretch. We shall see.
IM A BIG CLAY FAN WHEN HE GOES POSITIVE BABY!!!
Yeah but the FDA looked weak and could not even cite a hard and fast rule of the PI threshold of 5.
Plus, denying it based on a subset of the population could have enormous implications downstream.
So the FDA issues a CRL on a drug that is otherwise safer and more effective with millions of women because a subset of the population doesn’t meet the PI # (obese patients).
Apply that logic to all new drugs—that’s a brilliant way to foster innovation.
Agree 100%
FK ALGOS. THIS IS OVER $3 BY THANKSGIVING.
FDA Panel on their heals. As a hey should be.
DEAD WRONG. ITS GOING TO HAPPEN.
To penalize a safe and effective product based on a single vertical (obese end users) that otherwise would be accessible to millions of women is crazy.
Imagine the FDA applies that theory across the board is lunacy.
Good for you. Welcome Burpi. You actually do know some stuff. Lol.
Profit my friend
It’s kinda sad but expected. In December 2017 when Khoso and Chew started changing their tune and started talking not about a pre NDA meeting, but PRE PRE NDA meeting, it made me leery.
Pushing NDA into mid 2020 tells me Khoso and Chew Were being duplicitous about the time line, or worse, the FDA may actually have concerns about the CRO SNAFU and the ensuing stellar P value.
I hope my opinion is dead wrong. Either way I may take a position in Jan or Feb. I honestly don’t know where it will be trading, but I can now see $2-3 or worse
Sad. Good luck to you.
Hi.
WOW. THOUGHT PROVOKING.
I don’t see a near term catalyst so I anticipate a slow drift south for the next 6 months. There will be spikes from time to time but absent a buyout or partnership, which I don’t anticipate until after NDA submission (at a minimum).
I’d you are invested and don’t mind the wait, grab a cold corona and let it ride.
This will likely trade in the $3-$4 range before it trades in the $10 range. If Tutes keep buying to prop it up. Then I bet it may trade in the $4-$5 range until news gives it a boost.
That said, I do think 2020 is finally the year and could easily see this going beast mode the second half of 2020.
Good luck to you.
Yeah i didn’t factor in Tute buying. It’s increased since last year so the likely in the $5 range. Hope I’m wrong.
Eject sequence initiated in early August. Now an NDA decision not until second half of 2020? WAFJ. I made a killing on this since April 2018, but call options were terrible, lol.
There is no secret buyer, IMO; Elliot continues to enrich themselves; and no NDA decision for at least another 9 months??? The opportunity cost for parking money here for all that time? No thanks.
I wouldn’t at all be surprised if CRMD has another offering or fires up the ATM in Jan-Feb 2020. Absent a partnership or buyout (not likely, IMO) I could see this settling in at $2.50-$3.00 for the long winter nap.
Given the urgent need of a drug to combat hospital catheter infections, I’m starting to wonder out loud if the FDA is double, triple, and quadruple checking the data, given the insanely high P value—particularly after the CRO catastrophe.
I have a small position so I hope I’m wrong. For now, on to greener pastures. I’ll likely take another look in the spring of 2020.
Good luck Janey!
Thanks Clay.
CHOO CHOOOO!
I took a nice position. Let’s hope 3rd time’s the charm!
BOOM CHAKALAKA!!!
Agreed. I kept my initial position in the event of partnership or BO but pulled the rest.
Don’t expect catalyst until 2020. Chew and Khoso played fast and loose with possible LPAD dates last year. Shame on them, IMO.
I dunno. Management can’t seem to pull their heads out of their asses long enough to generate value to shareholders. Last year and early this year were great. Right now, this blows.
SHITFIRE!!! NO SECOND PHASE 3 NEEDED.
ITS ON LIKE DONKEY KONG!
HOLY CAT FIGHT!!!
WE ARE ALL FOR CRMD!
GIDDY UP, GANG!!!
No clue but I think we’re set for a monster week. News imminent, IMO.
SWEET. SLOW AND STEADY BABY!!!
Does this site even work any more. I can’t log on.
LoL. Finally contracts kicking ass!!!
Wow. Stellar volume.
BWAHAHAHA.
OOOCHIE GOOCHIE CELLUCI.
WAFJ.
Another day, another busted set of options. Nice job, Clown show Khoso.
??
ARE WE EVER GOING TO CATCH A BREAK?
Ha. Vent away. I know the feeling for sure.
Trust me, it’s not too late to get back in. Not by a long shot.
KHOSO. DO THIS, BABY.